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OBJECTIVE: The present study aimed to investigate the relationship between obesity and mortality in patients
with community-acquired pneumonia (CAP) in China.
METHODS: In total, 909 patients with CAP were recruited for this study from January 2010 to June 2015.
All patients were selected and divided into 4 groups according to their body mass index (BMI) values. All
patients’ clinical information was recorded. The associations among mortality; BMI; the 30-day, 6-month and
1-year survival rates for different BMI classes; the etiology of pneumonia in each BMI group; and the risk factors
for 1-year mortality in CAP patients were analyzed.
RESULT:With the exception of the level of C-reactive protein (CRP), no other clinical indexes showed significant
differences among the different BMI groups. No significant differences were observed among all groups in
terms of the 30-d and 6-month mortality rates (p40.05). There was a significantly lower risk of 1-year mortality
in the obese group than in the nonobese group, (po0.05). Logistic regression analysis showed that there were
seven independent risk factors for 1-year mortality in CAP patients, namely, age, cardiovascular disease,
cerebrovascular disease, obesity, APACHE II score, level of CRP and CAP severity.
CONCLUSION: Compared with nonobese patients with CAP, obese CAP patients may have a lower mortality rate,
especially with regard to 1-year mortality, and CRP may be associated with the lower mortality rate in obese
individuals than in nonobese individuals.
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’ INTRODUCTION
Community-acquired pneumonia (CAP) is a common
disease that frequently causes hospitalization and death in
the elderly (1). As the 2010 Global Burden of Disease Study
reported, lower respiratory tract infections, including pneu-
monia, have become the fourth most common cause of death
worldwide, exceeded only by ischemic heart disease, stroke
and chronic obstructive pulmonary disease (COPD) (2).
Studies have already demonstrated several relevant risk
factors for CAP, such as age465 years, smoking, alcoholism,
weight loss, immunosuppressive conditions, cardiovascu-
lar disease, poor functional and nutritional statuses, heart
disease, renal disease, cerebrovascular disease and chronic
obstructive pulmonary disease (COPD) (3). Additionally,
environmental exposure to substances such as second-hand
smoke, gases, fumes and chemicals also may lead to CAP (4).
Compared with younger age groups, the elderly have
significant differences in terms of their demographics, risk
factors, clinical presentations, and disease etiologies (5).
Although there is no information about the microbial etio-
logy of CAP in the current clinical guidelines, Streptococcus
pneumonia, Staphylococcus aureus and Enterobacteriaceae are
considered the main causes of pneumonia in the elderly; some
previous studies also found that Chlamydophila pneumoniae
and viruses can cause pneumonia in the elderly (6). Due to
special conditions pertaining to elderly individuals, elderly
patients with CAP always have poor prognoses, with a high
mortality rate of approximately 5-15% (7); this high mortality
rate remains a challenge in the clinical setting.DOI: 10.6061/clinics/2019/e608
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Obesity is generally considered a major risk factor for
many diseases, such as hypertension, cardiovascular disease,
lipid disorders, and type 2 diabetes (8). However, it is
thought that patients a higher body mass index (BMI) values
may have lower mortality rates in epidemiological studies
(9). Recently, it was found that the mortality due to CAP is
lower in obese elderly patients than in normal weight elderly
CAP patients (10,11). However, due to a lack of adequate
data, the mechanism underlying this difference is not clear,
and the relationship remains contentious.
To the best of our knowledge, few studies have focused on
the relationship between obesity and long-term mortality.
The present study aimed to explore the impact of obesity on
long-term mortality in CAP patients older than 55 years, as
well as the possible mechanisms underlying this effect. This
study may provide more clinical evidence and a better
understanding of lower mortality in obese patients than in
nonobese patients with CAP.
’ METHODS
Patients
In the present study, a retrospective analysis was con-
ducted with 909 of the 1013 patients older than 55 years with
CAP who presented at Wuhan People’s Hospital of Dongxihu
District, China, from January 2010 to June 2015. The diag-
nostic criteria for CAP were as follows: 1) fever (438oC),
cough, purulent sputum or change in the characteristics of the
respiratory secretions; 2) a radiographic infiltrate compatible
with pneumonia; and 3) laboratory data, such as leucopenia,
leukocytosis, and increased arterial-alveolar gradient (6).
Patients with immunosuppression, organ transplantation,
active thoracic malignancy, hospital-acquired pneumonia,
pulmonary embolism, chemotherapy, or corticosteroid ther-
apy were excluded. All patients were treated according to the
local management protocols for CAP. Patients were divided
into different groups according to body mass index (BMI)
values as follows: 1) obese (BMI430), 2) overweight (BMI 25
to o30), 3) normal (BMI 18.5 to o25), and 4) underweight
(BMIo18.5). The study was approved by the Ethics Commit-
tee of Wuhan People’s Hospital of Dongxihu District.
Data collection and patient assessment
All patients underwent clinical and laboratory evaluations.
Baseline observations (including blood pressure and respira-
tory frequency) and standard blood tests (complete blood
count, liver function tests, coagulation profile, white blood
cell count (WBC), and the determination of the levels of urea,
electrolytes, C-reactive protein (CRP), procalcitonin (PCT),
interleukin-1 (IL-1) and tumor necrosis factor (TNF-a)) were
performed upon patient admission. Biomarker levels were
measured within 24h after admission.
Acute Physiology and Chronic Health Enquiry (APACHE-
II) scores and the Pneumonia Severity Index (PSI) were used
to assess the risk of CAP in the patients (12,13).
Of the initial 1013 patients, 104 patients were excluded,
and 909 (89.73%) patients were included. These patients had
a known 1-year survival status and BMI. We also recorded
the 30-day survival, 6-month survival and 1-year survival for
different BMI classes to determine the relationship between
BMI and mortality. All patients were followed for 1 year by
telephone or outpatient follow-up visits. Furthermore, the
etiology of pneumonia was also studied according to BMI
group was in this report. The detailed clinical information for
all patients is listed in Table 1.
Statistical analysis
Patient characteristics are presented as medians (IQR
5th-95th percentiles), and frequencies are expressed as
percentages. Comparisons between two groups were per-
formed with Student’s t-test, and comparisons among three
or more groups were conducted using one-way analysis of
variance (ANOVA) followed by the Tukey post hoc test. The
Chi-square test was used to compare the rates. For the
survival analysis, survival time was calculated from the date
of hospital discharge to the date of death up to 1 year, and
Kaplan–Meier curves were generated. The association
between mortality and BMI class was further assessed by
Cox regression analysis adjusted for the PSI scores (model
1=adjusted for severity), sex, age, APACHE II scores,
cardiovascular diseases, and other comorbidities including
biomarkers (model 2=fully adjusted) with the normal BMI
group (18.5 to 15 kg/m2) defined as the reference group.
Moreover, hazard ratios (HRs) with 95% confidence intervals
(CIs) were used to present the results of the time to the event
analysis. For logistic analysis, univariate analysis was
performed using w2 tests and Student’s t-tests as described
above, and the significant factors in the univariate analysis
were included in logistic multivariable regression to define
possible risk factors for 1-year mortality in patients. Multi-
variable analysis was performed with logistic regression
models with a stepwise adjustment method.
All calculations were performed with SPSS version 18.0
(SPSS Inc., Chicago, USA). A p-value o0.05 was considered
statistically significant.
’ RESULTS
Basic clinical information for all included patients
According to the BMI levels, out of the total 909 CAP
patients older than 55 years old, 73 (7.7%) were in the
underweight group, 409 (45.3%) were in the normal weight
group, 285 (31.4%) were in the overweight group, and 142
(15.6%) were in the obese group. Clinical characteristics,
symptoms, signs and laboratory test results were recorded
on admission, and the patients were classified by BMI.
The results are shown in Table 1. The median duration of
hospital stay for the study groups was 5 days (IQR 3-13 days),
and the longest mean duration was for the underweight
group, followed by the obese group. However, there were no
significant differences in the duration of hospital stay among
the groups. Regarding the inflammatory factors, there were no
significant differences between different groups in terms of the
WBC count (p=0.162), PCT level (p=0.982), IL-1 level (p=0.658),
or TNF-a level (p=0.102), but a significant difference was
observed in the level of CRP in different groups (p=0.045).
Association between mortality and BMI classes after
30 days, 6 m, and 1 year
In this study, we also followed patient mortality 30 days,
6 months and 1 year after their discharge from the hospital,
and the mortality rates were 4.7% (95% CI 3.4-6.8), 8.6%
(95% CI 8.3-11.9) and 14.9% (95% CI 12.4-18.2), respectively
(Table 2). In this analysis, the normal weight group (BMI
18.5-25.0) was the reference group. Model 1 and model 2
represent different BMI groups. The association between
higher BMI and 30-day mortality and 6-month mortality was
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not significantly different between the two models. However,
mortality was significantly lower in the obese group than in
the reference group in models 1 and 2 (po0.05) (Table 2 and
Figure 1). To confirm whether inflammatory factors can
explain the reduced mortality in the obese group, these
factors were also included in the fully adjusted model.
Moreover, the effect of obesity on mortality was not changed
by the inclusion of biomarker levels.
Distribution of etiologies in different BMI classes
Finally, this paper studied the distribution of etiologies in
different BMI classes (Table 3). The most frequent etiology in
patients was infection with S. pneumonia, followed by
pneumococcal bacteremia and infection with Haemophilus
influenza. No significant differences were found among the
four groups regarding the prevalence of pathogens.
Risk factors for 1-year mortality in CAP patients
Finally, we investigated the risk factors for 1-year mortality
in CAP patients. Risk factors associated with mortality in
CAP patients were compared with those in living patients,
and the results are shown in Table 4. Among the fifteen
factors investigated, seven factors, namely, age, cardiovas-
cular disease, cerebrovascular disease, obesity, APACHE II
scores, and severity levels of CRP and CAP, were signifi-
cantly different in deceased patients than in living patients
(po0.05). These factors were further analyzed by multi-
variable logistic regression analysis. The Hosmer-Lemeshow










N 909 73 (7.7%) 409 (45.3%) 285 (31.4%) 142 (15.6%)
Age (y), median (IQR) 72 (57-83) 70 (56-85) 74 ( 57-84) 75 (60-83) 69 (55-79) 0.211
Fever (438oC), n (%) 633 (69.6) 50 (68.5) 286 (69.9) 205 (71.9) 92 (64.8) 0.438
Cough 335 (36.9) 33 (45.2) 143 (35.0) 108 (37.9) 51 (35.9) 0.604
Median duration of admission (d) ,
median (IQR)
5 (3-13) 7 (3-12) 5 (2-11) 5 (3-13) 6 (3-12) 0.185
Female, n (%) 431 (47.4) 32 (43.8) 213 (52.0) 123 (43.2) 63 (44.4) 0.560
Current smoker, n (%) 227 (25.0) 18 (24.7) 110 (26.9) 74 (26.0) 25 (17.6) 0.398
Cardiovascular disease, n (%) 261 (28.7) 13 (17.8) 110 (26.9) 76 (26.7) 32 (22.5) 0.380
Cerebrovascular disease, n (%) 103 (11.3) 8 (11.0) 43 (10.5) 32 (11.2) 20 (14.1) 0.857
Hypertension, n (%) 211 (23.2) 12 (16.4) 85 (20.8) 74 (26.0) 40 (28.2) 0.188
Type II diabetes, n (%) 185 (20.4) 9 (12.3) 76 (18.6) 65 (22.8) 35 (24.6) 0.128
Scores of APACHE II 18 (8B31) 19 (9B28) 17 (8B31) 21 (8B29) 18 (9B28) 0.235
Laboratory findings at admission,
median (IQR)
WBC 12.2 (8.9-16.3) 13.8 (11.3-17.8) 12.5 (8.7-17.6) 12.3 (9.2-15.9) 11.4 (9.0-16.2) 0.162
CRP (mg/L) 154.4 (74.0-237.0) 132.1 (67.3-217.9) 151.6 (75.8-243.5) 157.3 (74.5-245.0) 189.3 (97.3-278.2) 0.045
PCT (ug/L) 0.52 (0.16-3.31) 0.61 (0.22-3.89) 0.54 (0.17-3.24) 0.59 (0.21-3.01) 0.41 (0.15-3.42) 0.982
TNF-a (pg/mL) 13.5 (11.2-20.5) 15.6 (13.43-21.6) 12.5 (10.33-17.03) 13.5 (11.42-21.34) 14.2 (11.8-19.8) 0.102
IL-1 (ng/L) 27.8 (13.5-30.9) 25.6 (12.3-30.2) 27.2 (13.6-29.9) 26.1 (12.9-31.4) 30.4 (16.7-34.8) 0.658
CAP severity, n (%)
PSI grade 1 109 (12.0) 9 (12.3) 54 (13.2) 31 (10.9) 15 (10.6) 0.924
PSI grade 2 150 (16.5) 12 (16.4) 70 (17.1) 44 (15.4) 24 (16.9) 0.989
PSI grade 3 165 (18.2) 15 (20.5) 74 (18.1) 55 (19.3) 21 (14.8) 0.749
PSI grade 4 331 (36.4) 24 (32.9) 143 (35.0) 106 (37.1) 58 (40.8) 0.900
PSI grade 5 154 (16.9) 13 (17.8) 68 (16.6) 49 (17.2) 24 (16.9) 0.813
Mortality, n (%)
30 d 43 (4.7) 2 (2.7) 19 (4.6) 17 (6.0) 5 (3.5) 0.676
6 m 76 (8.4) 4 (5.5) 40 (9.8) 25 (11.6) 7 (4.9) 0.350
1 yr 151 (14.9) 11 (15.1) 70 (17.1) 59 (20.7) 11 (7.7) 0.072
a Compared among the 4 groups.
Table 2 - Association between mortality and BMI classes after 30 d, 6 m, and 1 yr.
Mean % (95% CI) 30 d 4.7 (3.4-6.8)
HR adj. (95% CI)
p-value 6 m 8.6 (8.3-11.9)
HR adj. (95% CI)
p-value 1 y 14.9 (12.4-18.2)
HR adj. (95% CI)
p-value
Model 1: Severity adjusted
Normal wright Reference Reference Reference
Underweight 0.534 (0.075-4.145 0.567 0.925 (0.388-2.250) 0.831 0.935 (0.580-1.604) 0.912
Overweight 1.201 (0.543-2.340) 0.609 0.915 (0.642-1.413) 0.765 0.813 (0.627-1.044) 0.087
Obese 0.790 (0.274-2.109) 0.653 0.504 (0.312-1.107) 0.055 0.650 (0.457-0.789 0.007
Model 2: Full adjusted
Normal wright Reference Reference Reference
Underweight 0.450 (0.054-3.576) 0.417 1.101 (0.456-2.675) 0.754 1.002 (0.596-1.879) 0.825
Overweight 1.088 (0.521-2.165) 0.802 1.043 (0.702-1.615) 0.743 0.688 (0.596-1.022) 0.075
Obese 0.618 (0.217-1.879) 0.412 0.634 (0.410-1.201) 0.125 0.720 (0.501-0.954) 0.034
Note: Adjusted for PSI (Model 1), PSI/age/sex/ Scores of APACHE II /cardiovascular diseases /other comorbidities including biomarkers (Model 2).
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test showed that the model fit well (sig.=0.526). The results
showed that all seven factors were associated with and
independent risk factors for 1-year mortality in CAP patients
(Table 5). These results were consistent with the results of the
analysis of the relationship between obesity and 1-year
mortality in CAP patients and thus further demonstrated the
relationship between these factors.
’ DISCUSSION
Community-acquired pneumonia (CAP) remains a leading
infectious cause of morbidity and mortality (14), and it
frequently causes hospitalization and death in the elderly.
A range of lifestyle factors and underlying medical condi-
tions, such as alcoholism, smoking, and chronic heart diseases,
Table 3 - Etiology of Pneumonia by BMI group.
Overall Underweight
(BMI o18.5) n (%)
Normal weight
(BMI 18.5-25.0) n (%)
Overweight
(BMI 25.0-30.0) n (%)
Obese
(BMI 430) n (%)
p-value
909 73 (7.7%) 409 (45.3%) 285 (31.4%) 142 (15.6%)
Streptococcus pneumoniae 371 (40.8) 31 (49.3) 166 (40.6) 110 (38.6) 64 (41.5) 0.440
Pneumococcal bacteremia 113 (12.4) 11 (15.1) 51 (12.5) 36 (12.6) 15 (10.6) 0.809
Haemophilus influenzae 86 (9.5) 6 (8.2) 38 (9.3) 29 (10.2) 13 (9.2) 0.971
Aspiration pneumonia 87 (9.6) 7 (9.6) 44 (10.8) 27 (9.5) 9 (6.3) 0.717
Legionella pneumophila 78 (8.6) 5 (6.8) 31 (7.6) 27 (9.5) 15 (10.5) 0.777
Staphylococcus aureus 17 (1.9) 2 (2.7) 7 (1.7) 6 (2.1) 2 (1.4) 0.921
Gram-negative bacilli 36 (4.0) 3 (4.1) 18 (4.4) 12 (4.2) 3 (2.1) 0.808
Pseudomonas aeruginosa 40 (4.4) 2 (2.7) 17 (4.2) 13 (4.6) 8 (5.6) 0.786
Atypical agents 36 (4.0) 3 (4.1) 18 (4.4) 12 (4.2) 3 (2.1) 0.808
Other 45 (5.0) 3 (4.1) 19 (4.6) 13 (4.6) 10 (7.0) 0.787
Table 4 - Risk factors associated with 1 year mortality of CAP patients compared with the survival patients.
Live, n=758 Death, n=151 p-value
Age (y), median (IQR) 72 (55B79) 79 (62B84) 0.046
Female, n (%) 351 (46.3) 80 (53.0) 0.354
Current smoker, n (%) 192 (25.3) 32 (21.2) 0.490
Cardiovascular disease, n (%) 199 (26.2) 62 (41.1) 0.026
Obesity, n (%) 131 (17.3) 11 (7.3) 0.031
Cerebrovascular disease, n (%) 72 (9.2) 31 (20.5) 0.025
Hypertension, n (%) 171 (22.6) 40 (26.5) 0.522
Type II diabetes, n (%) 143 (18.9) 42 (27.8) 0.137
Scores of APACHE II 17 (8-29) 21 (13-31) 0.005
Laboratory findings at admission, median (IQR)
WBC 12.6 (8.7B15.9) 13.1 (8.9B16.4) 0.561
CRP (mg/L) 157.5 (75.6B262.8) 151.6 (71.5B231.6) 0.012
PCT (ug/L) 0.51 (0.16B3.39) 0.53 (0.18B3.28) 0.457
TNF-a (pg/mL) 13.6 (11.4B21.9) 13.9 (11.6B22.0) 0.538
IL-1 (ng/L) 28.1 (12.5B30.5) 28.6 (12.9B32.1) 0.649
CAP severity, n (%)
PSI grade 1 106 (14.0) 3 (2.0) 0.000
PSI grade 2 135 (17.8) 15 (9.9)
PSI grade 3 144 (19.0) 21 (13.9)
PSI grade 4 283 (37.3) 48 (31.8)
PSI grade 5 90 (11.9) 64 (42.4)
Figure 1 - Kaplan–Meier curve of survival according to different
body mass index.
Table 5 - Risk factors associated with 1 year mortality of CAP
patients by Logistic multivariate regression analysis.
Wald Odds ratio 95% CI p-value
Age 2.653 0.936 (0.061B2.126) 0.006
Cardiovascular disease 13.447 1.973 (1.376B2.835) 0.000
Cerebrovascular disease 5.735 3.428 (1.537B9.825) 0.000
Obesity condition 1.456 1.556 (1.337B2.537) 0.002
Level of CRP 4.369 2.213 (1.525B4.136) 0.003
Scores of APACHE II 2.356 1.785 (1.467B3.215) 0.000
CAP severity 7.674 5.963 (1.485B8.214) 0.000
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are associated with an increased risk of CAP (3). However,
despite the substantial progress in diagnostic methods and
treatment technology for CAP, the poor prognosis of CAP is
still a large problem in the clinical setting.
Recently, the phenomenon that obese elderly patients with
CAP might have a lower mortality rate than that of normal
weight CAP patients has attracted scholars’ attention.
Several studies have reported related findings; however,
a deeper understanding and more clinical evidence are still
needed to demonstrate the relationship between obesity and
lower mortality in elderly patients with CAP, especially with
regard to the relationship between obesity and long-term
mortality in CAP patients. In this report, we demonstrated
that obese individuals might have a lower mortality rate
than nonobese individuals, especially with regard to 1-year
survival after admission, and we demonstrated that the effect
might be associated with the level of CRP. We also demon-
strated that obesity might be an independent risk factor for
mortality in CAP patients, which was rarely seen in previous
studies.
First, we found that, unlike the CRP level, the levels of PCT,
TNF-a and IL-1 showed no significant difference in obese and
nonobese CAP patients. Singanayagam et al demonstrated
that compared with nonobese patients, obese patients had
higher levels of C-reactive protein (7). Braun N et al found that
the WBC counts and PCT levels did not vary significantly in
different BMI groups (15). The results of these related studies
are consistent with our findings.
Second, we found that elderly obese patients (BMI430
kg/m2) with CAP had lower mortality rates than other
groups of patients. However, the difference in the mortality
rate was only found to be significant for the 1-year mortality
rate, while the differences were not significant for the 30-day
mortality and 6-month mortality rates in different BMI
groups, indicating that the influence of obesity on mortality
in CAP patients might be mainly long term. A previous
report (15) found lower mortality rates occurred in the obese
group than in the nonobese group after 6 years and also
found no differences in the 30-day and 1-year mortality rates
in different BMI groups. In addition, Hong et al demon-
strated that frailty and readmission due to CAP were asso-
ciated with higher 1-year mortality rates in older patients
hospitalized for CAP (16). These different results might be due
to different study populations and the different conditions of
the patients, and they need further research for confirmation.
The etiology of pneumonia was also investigated in our study.
The distributions of risk factors were not significantly different
in different BMI classes, which was similar to the findings of
other related studies (17).
Finally, we investigated the possible risk factors for
mortality in CAP patients, and the results showed that age,
cardiovascular disease, cerebrovascular disease, obesity, APA
CHE II scores and CAP severity were all independent risk
factors for 1-year mortality in CAP patients. Some related
studies have identified the risk factors for mortality in CAP
patients. Que et al studied CAP patients in the ICU and
found that a CRP value at admissiono169.5 mg/L predicted
a fatal outcome (18). In a 5-year study of long-term mortality
after hospitalization for CAP, the authors found that age,
cardiovascular disease, COPD, immunocompromised status,
and low serum albumin level at admission were all inde-
pendent risk factors for long-term mortality in CAP patients
(19). However, whether obesity is an independent risk factor
for mortality in CAP patients or not remains controversial.
The study also had some limitations. First, the study sample
size was small. Second, the mechanism by which the level
of CRP influences mortality in obese CAP patients is still
unclear and needs further study.
In conclusion, the present study was a retrospective
analysis of the relationship between obesity and lower mor-
tality in patients 455 years with CAP. The results showed
that the obese group had a lower 1-year mortality rate than
the nonobese group, and the effect might be associated with
CRP levels at admission. Moreover, both obesity and CRP
levels were independent risk factors for 1-year mortality in
CAP patients. These results may provide more clinical
evidence and better understanding of reduced mortality in
obese CAP patients.
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